NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE EXTENDED-RELEASE- naltrexone hydrochloride and bupropion hydorchloride tablet, extended release 
AbbVie Inc.

----------

naltrexone HCl and bupropion HCl

PRINCIPAL DISPLAY PANEL - NDC: 51267-890-99 - 8 mg/90 mg 120-count Bottle Label

NDC 51267–89–099

8 mg/90 mg 120-count Bottle Label



NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE  EXTENDED-RELEASE
naltrexone hydrochloride and bupropion hydorchloride tablet, extended release
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:0051-0629
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
NALTREXONE HYDROCHLORIDE (UNII: Z6375YW9SF) (NALTREXONE - UNII:5S6W795CQM) NALTREXONE HYDROCHLORIDE8 mg
BUPROPION HYDROCHLORIDE (UNII: ZG7E5POY8O) (BUPROPION - UNII:01ZG3TPX31) BUPROPION HYDROCHLORIDE90 mg
Product Characteristics
ColorBLUEScoreno score
ShapeROUND (bi-convex) Size12mm
FlavorImprint Code NB;890
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0051-0629-12120 in 1 BOTTLE; Type 0: Not a Combination Product10/22/2014
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Approved Drug Product Manufactured Under ContractNDA20006310/22/2014
Labeler - AbbVie Inc. (078458370)

Revised: 10/2017
Document Id: 4f69a194-fc16-b659-80b8-45e39f872c7c
Set id: bad555b7-ca04-47e8-bf90-559262c6c06f
Version: 25
Effective Time: 20171019
 
AbbVie Inc.